Harrow Health (HROW) Reports In-Line Q1 EPS

Harrow Health (NASDAQ: HROW) reported Q1 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $24.97 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c